Atlas Trials

A Phase III Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer

Clinical trial NCT02691299 · COMPLETED

Trial details

NCT number
NCT02691299
Sponsor
Hutchison Medipharma Limited
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
NSCLC
Start date
2015-12-09
Primary completion
2018-09-21
Enrollment
527

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.